Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies.

Cookies policy

Data selected by Name covexin

Original name

Strength

Marketing authorisation number

Marketing authorisation holder:

ATCvet code

Species

Covexin 10

V/MRP/10/0020

Zoetis Belgium S.A., Beļģija

QI04AB01;QI02AB01

cattle; sheep

Vairāk

Medicinal product information

Pharmaceutical form:	suspension for injection
International name (active substance):	Clostridium perfringens, epsilon-toxoid (type D), Clostridium perfringens, beta-toxoid (type B and C), Toxoid Clostridium novyi, Clostridium tetani toxoid, C. perfringens type A toxoid, C. chauvoei whole culture, C. septicum toxoid, C. sordellii toxoid, C. haemolyticum toxoid
Distribution category:	To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release	Pfizer Animal Health S.A., Beļģija
Date of authorisation/renewal:	31-Mar-2015
Marketing authorisation valid until:	Unlimited time period
Marketing authorisation procedure:	MRP
Package leaflet:	[PDF] Skat_sadaļā_Zāļu_apraksts (23-Nov-2023)
Labelling text:	[PDF] Skat_sadaļā_Zāļu_apraksts (23-Nov-2023)
Summary of product characteristics:	[DOCX] Zāļu_informācija_ZA_M_LI (23-Nov-2023)

ID	Strength	Package size	Primary packaging	Labelling
V/MRP/10/0020-02		1	Polietilēna pudele, 50 ml	-
V/MRP/10/0020-03		1	Polietilēna pudele, 100 ml	-

Covexin 10

V/I/24/0063

Zoetis Belgium S.A., Beļģija

QI04AB01;QI02AB01

cattle; sheep

Vairāk

Pharmaceutical form:	suspension for injection
International name (active substance):	Clostridium perfringens, epsilon-toxoid (type D), Clostridium perfringens, beta-toxoid (type B and C), Toxoid Clostridium novyi, Clostridium tetani toxoid, C. perfringens type A toxoid, C. chauvoei whole culture, C. septicum toxoid, C. sordellii toxoid, C. haemolyticum toxoid
Distribution category:	To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release	Pfizer Animal Health S.A., Beļģija
Date of authorisation/renewal:	23-Sep-2024
Marketing authorisation valid until:	22-Sep-2029
Marketing authorisation procedure:	I
Package leaflet:	[DOCX] 23092024_LI (23-Sep-2024)
Labelling text:	See products section
Summary of product characteristics:	-

ID	Strength	Package size	Primary packaging	Labelling
V/I/24/0063-01		1	Polietilēna pudele, 100 ml	[PDF]

Covexin 10

V/I/24/0024

Zoetis Belgium S.A., Beļģija

QI04AB01;QI02AB01

cattle; sheep

Vairāk

Pharmaceutical form:	suspension for injection
International name (active substance):	Clostridium perfringens, epsilon-toxoid (type D), Clostridium perfringens, beta-toxoid (type B and C), Toxoid Clostridium novyi, Clostridium tetani toxoid, C. perfringens type A toxoid, C. chauvoei whole culture, C. septicum toxoid, C. sordellii toxoid, C. haemolyticum toxoid
Distribution category:	To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release	Pfizer Animal Health S.A., Beļģija
Date of authorisation/renewal:	25-Mar-2024
Marketing authorisation valid until:	24-Mar-2029
Marketing authorisation procedure:	I
Package leaflet:	[DOCX] 22032024LI (25-Mar-2024)
Labelling text:	See products section
Summary of product characteristics:	-

ID	Strength	Package size	Primary packaging	Labelling
V/I/24/0024-01		1	Polietilēna pudele, 100 ml	[PDF]

3 records · Download